pyrazines has been researched along with thromboxane a2 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 5 (62.50) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 1 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, KJ; Wu, YS | 1 |
Liu, SY; Xu, YY; Zhu, JY | 1 |
Chen, S; Li, JW; Ma, SX; Wang, Y; Yan, YH | 1 |
Feng, J; Liu, R; Tang, S; Wu, G | 2 |
Feng, J; Tang, S; Wu, G | 1 |
Dong, H; Tang, R; Tong, J; Wang, Y; Xu, J | 1 |
Chen, H; Chen, K; Chen, Y; Chu, J; Li, L; Li, Q; Liu, L; Peng, J; Shen, A | 1 |
8 other study(ies) available for pyrazines and thromboxane a2
Article | Year |
---|---|
[Effects of a compound prescription of blood activator and tetramethylpyrazine on the biosynthesis of thromboxane A2].
Topics: Animals; Fibrinolytic Agents; Male; Medicine, Chinese Traditional; Medicine, East Asian Traditional; Plant Extracts; Plants, Medicinal; Pyrazines; Rabbits; Thromboxane A2; Thromboxane-A Synthase; Thromboxanes | 1985 |
[The effects of Salvia miltiorrhizae Bge and Ligustrazine on thromboxane A2 and prostacyclin in pregnancy induced hypertension].
Topics: Adult; Drugs, Chinese Herbal; Epoprostenol; Female; Humans; Plant Extracts; Pre-Eclampsia; Pregnancy; Pyrazines; Salvia miltiorrhiza; Thromboxane A2 | 1994 |
Effect of new thromboxane A2 synthesis inhibitor tetramethyl-pyrazine on pancreatic transplantation in diabetic rats.
Topics: Albuminuria; Animals; Benzofurans; beta 2-Microglobulin; Cyclosporine; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enzyme Inhibitors; Immunosuppressive Agents; Kidney; Organ Size; Pancreas Transplantation; Pyrazines; Rats; Rats, Wistar; Thromboxane A2; Thromboxane-A Synthase; Transplantation, Isogeneic | 1996 |
Pretreatment with tetramethylpyrazine increases the release of PGI2 and decreases TXA2 release in isolated rat heart.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Heart; In Vitro Techniques; Male; Myocardium; Pyrazines; Rats; Rats, Sprague-Dawley; Reference Values; Thromboxane A2; Vasodilator Agents | 1996 |
Effects of tetramethylpyrazine on the release of PGI2 and TXA2 in the hypoxic isolated rat heart.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Coronary Circulation; Epoprostenol; Heart; Hypoxia; In Vitro Techniques; Male; Myocardium; Perfusion; Platelet Aggregation Inhibitors; Pyrazines; Rats; Rats, Sprague-Dawley; Thromboxane A2; Thromboxane B2; Time Factors; Vasodilator Agents | 1997 |
The effects of tetramethylpyrazine on the incidence of arrhythmias and the release of PGI2 and TXA2 in the ischemic rat heart.
Topics: Animals; Arrhythmias, Cardiac; Epoprostenol; Heart; Male; Myocardial Ischemia; Pyrazines; Rats; Rats, Sprague-Dawley; Thromboxane A2 | 1999 |
Inhibitory effects of ligustrazine, a modulator of thromboxane-prostacycline-nitric oxide balance, on renal injury in rats with passive Heyman nephritis.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Epoprostenol; Female; Fluorescent Antibody Technique, Direct; Glomerular Basement Membrane; Glomerulonephritis; Immunoglobulin G; Kidney Glomerulus; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitrites; Proteinuria; Pyrazines; Rats; RNA, Messenger; Thromboxane A2 | 2004 |
Ligustrazine inhibits platelet activation via suppression of the Akt pathway.
Topics: Animals; Calcium; Hemorrhage; Insulin-Like Growth Factor I; Male; Phosphorylation; Platelet Activation; Platelet Aggregation; Proto-Oncogene Proteins c-akt; Pyrazines; Rats, Sprague-Dawley; Signal Transduction; Thromboxane A2 | 2019 |